It is a done deal, imo. The shorts are only fooling themselves in my opinion; may be they are buying a little bit of time - that's all, imo. The shorts are goin to learn the hardest way I think.
what I disagree with you on is that the OFFICIAL TLD (yes a world first invented by NWBO), will green light new medium seized private equity institutions to start buying the stock. The reason being is that in that case, the DD department of those PE firms can tell the buying stock traders on another department that the biotech itself has confirmed Topline which thus then removes much more risk than before.
This will then of course increase SP for they will buy in large quantities.